Early
diagnosis of hepatic inflammation is the key to timely treatment
and avoid the worsening of liver inflammation. Near-infrared fluorescence
(NIRF) probes have high sensitivity but low spatial resolution in
lesion imaging, while photoacoustic (PA) imaging has good spatial
location information. Therefore, the development of a NIRF/PA dual-modal
probe integrated with high sensitivity and spatial location feedback
can achieve an accurate early diagnosis of hepatic inflammation. Here,
we report an activatable NIRF/PA dual-modal probe (hCy-Tf-CA) for the detection of the superoxide anion (O2·–) in early hepatic inflammation. hCy-Tf-CA showed high
selectivity and sensitivity for detecting O2·– fluctuation in vitro. More importantly, by introducing
hepatocyte-targeting cholic acid (CA), the probe successfully
achieved accurate in situ imaging of acute inflammatory
liver injury (AILI) and autoimmune hepatitis (AIH) in vivo. The introduced CA not only promotes the hepatic targeting
accumulation of probes but also improves the performance of low background
dual-modal imaging in vivo. Therefore, hCy-Tf-CA provides an effective strategy for significantly improving in situ imaging performance and holds great potential for
early, sensitive, and accurate diagnosis of hepatic inflammation